Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Robigo raises Series A funding led by Leaps by Bayer for engineered microbial crop protection. The biotech company plans to accelerate commercial launch of biopesticides targeting fungal diseases.

PRIVATESep 17, 2026•about 3 hours ago

Round Type

Series A

United StatesBiotechnologyAgriculture and Farming

Investors

Endeavor8Congruent VenturesSvg ThriveIllumina VenturesLeaps By Bayer

Description

Robigo, a biotechnology company developing crop protection products using engineered microbes, RNA interference and CRISPR technologies, has raised a Series A funding round led by Leaps by Bayer. The round also included participation from Illumina Ventures, SVG Thrive, Congruent Ventures and Endeavor8. Robigo plans to use the funding to accelerate the commercial launch of microbial biopesticides targeting fungal diseases in soybeans and specialty crops in the United States. The company will also expand its pipeline to tackle additional soil-borne pathogens across broadacre agriculture.

Company Information

Company

Robigo

Location

United States

About

Robigo is a biotechnology company developing crop protection products using engineered microbes, RNA interference (RNAi), and CRISPR technologies. The company's ARGO platform uses synthetic biology and computational design to engineer living microbes capable of delivering targeted crop protection against soil-borne pathogens. Robigo's products are designed as one-time applications that reduce development timelines from 3-5 years to less than 20 months. The company targets fungal diseases in soybeans and specialty crops, addressing a $10bn broadacre agriculture market.

Don't miss Robigo's next move

Get an email the moment Robigo raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Robigo's next move

See what Strategic adds

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Robigo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.